Recent

% | $
Quotes you view appear here for quick access.

ASTERIAS BIOTHERAPEU Message Board

  • ipstissueface ipstissueface Jul 25, 2014 4:17 PM Flag

    Our CEO Bio

    Mr. Pedro Lichtinger has been the Chief Executive Officer and President of Asterias Biotherapeutics, Inc. since Mr. Lichtinger served as the Chief Executive Officer and President of Optimer Pharmaceuticals, Inc. from May 2010 to February 2013. Mr. Lichtinger served as an Executive of Pfizer, Inc. from 1995 to 2009 and as the President of Pfizer's Global Primary Care Business Unit from 2008 to 2009, Area President, Europe from 2006 to 2008, President, Global Animal Health from 1999 to 2006, and Regional President Europe Animal Health from 1995 to 1999, where he oversaw operations in North America, Europe, Korea, and Australia with revenues of $23 billion, 15,000 employees, and more than 60 development projects. He served as the President of European Pharmaceutical Operations and oversaw all pharmaceutical products including primary care, oncology, specialty and generic. He served as President of Pfizer Animal Health Inc., Global Animal Health Business and Regional President Europe Animal Health. Before joining Pfizer, Mr. Lichtinger was an executive of Smith Kline Beecham, last serving as Senior Vice-President Europe Animal Health from 1987 to 1995. Mr. Lichtinger has over 30 years' experience in the animal health industry in the United States, Latin America and Europe. He also served in a variety of management positions within the animal health divisions of Pfizer and Smith Kline Beecham. His positions included: Country Manager of Brazil; International Business Development Director; Vice-President of southern Europe and Senior Vice-President of Europe. He has broad international and cross functional experience. Mr. Lichtinger serves as President at International Federation for Animal Health. He has been a Director of Asterias Biotherapeutics, Inc. since July 18, 2014. He has been a Director of BioTime, Inc. since August 2009 and serves as a Member of Board of Governors at Boys & Girls Clubs of America. He served as a Director at Optimer Pharmaceutical

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ASTYV
2.280.00(0.00%)Aug 12 3:53 PMEDT